Anti-Human CA9 Recombinant Antibody
-
产品编号
YR1222
-
别名
科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab
-
规格
- 1mg
- 5mg
Alias | 科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab |
Catalog Number | YR1222 |
Molecular Name | Girentuximab |
Host | Mouse |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Girentuximab (trade name Rencarex) is a chimeric IgG1 monoclonal antibody to carbonic anhydrase IX (CAIX). CAIX is expressed on the surface of most renal cancer cells and is hypothesized to be on the surface of other tumor cells. It is investigational agent in clinical trials for renal cell carcinoma. Its development was suspended as a "naked" or unconjugated antibody during phase III trials due to efficacy. |
CAS Number | 916138-87-9 |
Application | WB, FuncS, IF, Neut, ELISA, FCM, IP, PK, IHC, Activ |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CA9[Homo sapiens] |